Login to MyKarger

New to MyKarger? Click here to sign up.

Login with Facebook

Forgot your password?

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login
(Shibboleth or Open Athens)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

Original Research Article

Free Access

Risk Factors of Transition from Normal Cognition to Mild Cognitive Disorder: The PATH through Life Study

Cherbuin N.a · Reglade-Meslin C.a · Kumar R.a, b · Jacomb P.a · Easteal S.c · Christensen H.a · Sachdev P.d, e · Anstey K.J.a

Author affiliations

aCentre for Mental Health Research, bDepartment of Psychological Medicine, and cJohn Curtin School of Medical Research, Australian National University, Canberra, A.C.T., and dSchool of Psychiatry, University of New South Wales, and eNeuropsychiatric Institute, Sydney, N.S.W., Australia

Corresponding Author

Nicolas Cherbuin

Centre for Mental Health Research, Building 63

Australian National University

Canberra, A.C.T. 0200 (Australia)

Tel. +61 2 6125 3858, Fax +61 2 6125 0733, E-Mail nicolas.cherbuin@anu.edu.au

Related Articles for ""

Dement Geriatr Cogn Disord 2009;28:47–55

Do you have an account?

Login Information

Contact Information

I have read the Karger Terms and Conditions and agree.


Aims: The aim of this study was to identify physical and mental health and lifestyle predictors of transition from normal cognition to mild cognitive disorder (MCD). Methods: A total of 2,082 individuals, aged 60–64 years, were assessed at 2 time-points 4 years apart for mild cognitive impairment (MCI) and other MCDs. Results: The main predictors of conversion to MCI and to other mild cognitive disorders were past alcohol intake, current anxiety and depression medication, increased systolic blood pressure, and past smoking. Conclusion: Participants with a history of smoking or harmful alcohol consumption, hypertension, or who took medication for anxiety or depression were at increased risk of transitioning to MCI or any MCD. Strategies targeted at managing the above risk factors may have benefits in preventing mild cognitive decline in relatively healthy middle-aged individuals living in the community.

© 2009 S. Karger AG, Basel

Article / Publication Details

First-Page Preview
Abstract of Original Research Article

Accepted: May 15, 2009
Published online: July 23, 2009
Issue release date: August 2009

Number of Print Pages: 9
Number of Figures: 1
Number of Tables: 4

ISSN: 1420-8008 (Print)
eISSN: 1421-9824 (Online)

For additional information: http://www.karger.com/DEM

Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.